2,7-Dimethyl-1-thiaindan | 14422-08-3

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 2,7-Dimethyl-1-thiaindan
• 英文别名: 2,7-Dimethyl-2,3-dihydrobenzothiophene；2,7-dimethyl-2,3-dihydro-1-benzothiophene
• CAS: 14422-08-3
• 化学式: C₁₀H₁₂S
• 分子量: 164.271
• InChiKey: BPNDIQDRRQLQDM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND
  申请人：FUJIFILM Corporation

  公开号：EP3823054A1

  公开（公告）日：2021-05-19

  The present invention is to provide a photoelectric conversion element having excellent heat resistance. In addition, an imaging element and an optical sensor which include the photoelectric conversion element are provided. Furthermore, a compound applied to the photoelectric conversion element is provided. A photoelectric conversion element according to the present invention includes a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1). In Formula (1), Y1 represents a group represented by Formula (1-1) or a group represented by Formula (1-2).

  本发明旨在提供一种具有优异耐热性的光电转换元件。此外，还提供了包含该光电转换元件的成像元件和光学传感器。此外，还提供了一种应用于光电转换元件的化合物。根据本发明，光电转换元件依次包括导电薄膜、光电转换薄膜和透明导电薄膜，其中光电转换薄膜含有由式（1）表示的化合物。 在式 (1) 中，Y1 代表式 (1-1) 所代表的基团或式 (1-2) 所代表的基团。
• Gabapentin-containing Solid Compositions and Process for Preparing the Same
  申请人：AOMATSU Akira

  公开号：US20090156677A1

  公开（公告）日：2009-06-18

  The present invention provides a stabilized solid composition containing a 4-amino 3-substituted-butanoic acid derivative which can be obtained by incorporating a humectant as a stabilizer.
• US7309719B1
  申请人：——

  公开号：US7309719B1

  公开（公告）日：2007-12-18
• US8623407B2
  申请人：——

  公开号：US8623407B2

  公开（公告）日：2014-01-07
• [EN] AMIDE COMPOUND<br/>[FR] COMPOSÉ AMIDE
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2010018874A1

  公开（公告）日：2010-02-18

  A compound having GPR52 agonist activity or a salt thereof is provided. The compound can be provided as a preventive / therapeutic agent for schizophrenia or the like. The compound is represented by the following formula (Ia): wherein A represents -CONR2- or -NR2CO-, R2 represents a hydrogen atom or the like, B represents a hydrogen atom or the like, a ring CyI represents a six-membered aromatic ring which may have one or more substituents in addition to a group represented by -A-B, a ring Cy2 represents a six-membered ring which may be substituted with a halogen atom or the like, a ring Cy3 represents a five- or six-membered ring which may have one or more substituents; X represents C1-2 alkylene or the like, m represents an integer of 0 to 2, and a ring Cy4 represents a six-membered aromatic ring which may have one or more substituents.